{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:11:38Z","timestamp":1787170298472,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Faculty of Medical Sciences, Tarbiat Modares University Grant Reference Number: Med-75939"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Spinal Cord"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1038\/s41393-021-00687-5","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T02:02:54Z","timestamp":1631152974000},"page":"63-70","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Safety and feasibility of autologous olfactory ensheathing cell and bone marrow mesenchymal stem cell co-transplantation in chronic human spinal cord injury: a clinical trial"],"prefix":"10.1038","volume":"60","author":[{"given":"Homa","family":"Zamani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Soufizomorrod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Oraee-Yazdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariush","family":"Naviafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadhosein","family":"Akhlaghpasand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsoun","family":"Seddighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1972-7771","authenticated-orcid":false,"given":"Masoud","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"key":"687_CR1","first-page":"172","volume":"4","author":"S Mehrabi","year":"2013","unstructured":"Mehrabi S, Eftekhari S, Moradi F, Delaviz H, Pourheidar B, Azizi M, et al. Cell therapy in spinal cord injury: a mini-reivew. Basic Clin Neurosci. 2013;4:172\u20136.","journal-title":"Basic Clin Neurosci"},{"key":"687_CR2","doi-asserted-by":"crossref","unstructured":"Anna Z, Katarzyna J-W, Joanna C, Barczewska M, Joanna W, Wojciech M. Therapeutic potential of olfactory ensheathing cells and mesenchymal stem cells in spinal cord injuries. Stem Cells Int. 2017;2017:3978595.","DOI":"10.1155\/2017\/3978595"},{"key":"687_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3727\/096368914X678508","volume":"23","author":"R-H Chou","year":"2014","unstructured":"Chou R-H, Lu C-Y, Wei-Lee, Fan J-R, Yu Y-L, Shyu W-C. The potential therapeutic applications of olfactory ensheathing cells in regenerative medicine. Cell Transplant. 2014;23:567\u201371.","journal-title":"Cell Transplant"},{"key":"687_CR4","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/glia.20718","volume":"56","author":"KL Lankford","year":"2008","unstructured":"Lankford KL, Sasaki M, Radtke C, Kocsis JD. Olfactory ensheathing cells exhibit unique migratory, phagocytic, and myelinating properties in the X\u2010irradiated spinal cord not shared by Schwann cells. Glia. 2008;56:1664\u201378.","journal-title":"Glia."},{"key":"687_CR5","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1089\/neu.2019.6939","volume":"37","author":"AD Gilmour","year":"2020","unstructured":"Gilmour AD, Reshamwala R, Wright AA, Ekberg JA, St John JA. Optimizing olfactory ensheathing cell transplantation for spinal cord injury repair. J Neurotrauma. 2020;37:817\u201329.","journal-title":"J Neurotrauma"},{"key":"687_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s12038-013-9409-5","volume":"39","author":"R Taran","year":"2014","unstructured":"Taran R, Mamidi MK, Singh G, Dutta S, Parhar IS, John JP, et al. In vitro and in vivo neurogenic potential of mesenchymal stem cells isolated from different sources. J Biosci. 2014;39:157\u201369.","journal-title":"J Biosci"},{"key":"687_CR7","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.3727\/096368912X663532","volume":"22","author":"P Tabakow","year":"2013","unstructured":"Tabakow P, Jarmundowicz W, Czapiga B, Fortuna W, Miedzybrodzki R, Czyz M, et al. Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury. Cell Transplant. 2013;22:1591\u2013612.","journal-title":"Cell Transplant"},{"key":"687_CR8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/scrt516","volume":"5","author":"MVP Mendon\u00e7a","year":"2014","unstructured":"Mendon\u00e7a MVP, Larocca TF, de Freitas Souza BS, Villarreal CF, Silva LFM, Matos AC, et al. Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury. Stem Cell Res Ther. 2014;5:126.","journal-title":"Stem Cell Res Ther"},{"key":"687_CR9","doi-asserted-by":"publisher","first-page":"e11505","DOI":"10.15252\/emmm.201911505","volume":"12","author":"JM Griffin","year":"2020","unstructured":"Griffin JM, Bradke F. Therapeutic repair for spinal cord injury: combinatory approaches to address a multifaceted problem. EMBO Mol Med. 2020;12:e11505.","journal-title":"EMBO Mol Med"},{"key":"687_CR10","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s12035-016-9709-5","volume":"54","author":"J Zhang","year":"2017","unstructured":"Zhang J, Chen H, Duan Z, Chen K, Liu Z, Zhang L, et al. The effects of co-transplantation of olfactory ensheathing cells and schwann cells on local inflammation environment in the contused spinal cord of rats. Mol Neurobiol. 2017;54:943\u201353.","journal-title":"Mol Neurobiol"},{"key":"687_CR11","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jcyt.2013.03.012","volume":"15","author":"S Oraee-Yazdani","year":"2013","unstructured":"Oraee-Yazdani S, Hafizi M, Zali A-R, Atashi A, Ashrafi F, Seddighi A-S, et al. Safety and possible outcome assessment of autologous Schwann cell and bone marrow mesenchymal stromal cell co-transplantation for treatment of patients with chronic spinal cord injury. Cytotherapy. 2013;15:782\u201391.","journal-title":"Cytotherapy."},{"key":"687_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3727\/096368914X685014","volume":"23 1_suppl","author":"L Chen","year":"2014","unstructured":"Chen L, Huang H, Xi H, Zhang F, Liu Y, Chen D, et al. A prospective randomized double-blind clinical trial using a combination of olfactory ensheathing cells and Schwann cells for the treatment of chronic complete spinal cord injuries. Cell Transplant. 2014;23 1_suppl:35\u201344.","journal-title":"Cell Transplant"},{"key":"687_CR13","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1111\/j.1537-2995.2006.01041.x","volume":"46","author":"HM Khuu","year":"2006","unstructured":"Khuu HM, Patel N, Carter CS, Murray PR, Read EJ. Sterility testing of cell therapy products: parallel comparison of automated methods with a CFR\u2010compliant method. Transfusion. 2006;46:2071\u201382.","journal-title":"Transfusion."},{"key":"687_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/sc.2015.142","volume":"54","author":"S Oraee-Yazdani","year":"2016","unstructured":"Oraee-Yazdani S, Hafizi M, Atashi A, Ashrafi F, Seddighi A, Hashemi S, et al. Co-transplantation of autologous bone marrow mesenchymal stem cells and Schwann cells through cerebral spinal fluid for the treatment of patients with chronic spinal cord injury: safety and possible outcome. Spinal Cord. 2016;54:102\u20139.","journal-title":"Spinal Cord"},{"key":"687_CR15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.neulet.2018.01.008","volume":"668","author":"SM Hosseini","year":"2018","unstructured":"Hosseini SM, Sani M, Haider KH, Dorvash M, Ziaee SM, Karimi A, et al. Concomitant use of mesenchymal stem cells and neural stem cells for treatment of spinal cord injury: a combo cell therapy approach. Neurosci Lett. 2018;668:138\u201346.","journal-title":"Neurosci Lett"},{"key":"687_CR16","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.3390\/ijms20112698","volume":"20","author":"F Cofano","year":"2019","unstructured":"Cofano F, Boido M, Monticelli M, Zenga F, Ducati A, Vercelli A, et al. Mesenchymal stem cells for spinal cord injury: current options, limitations, and future of cell therapy. Int J Mol Sci. 2019;20:2698.","journal-title":"Int J Mol Sci"},{"key":"687_CR17","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1080\/14653240802165673","volume":"10","author":"Y Deng","year":"2008","unstructured":"Deng Y, Liu Y, Zhu W, Bi X, Wang Y, Ye M, et al. The co-transplantation of human bone marrow stromal cells and embryo olfactory ensheathing cells as a new approach to treat spinal cord injury in a rat model. Cytotherapy. 2008;10:551\u201364.","journal-title":"Cytotherapy."},{"key":"687_CR18","doi-asserted-by":"crossref","unstructured":"Wu S, Cui G, Shao H, Du Z, Ng JC, Peng C. The cotransplantation of olfactory ensheathing cells with bone marrow mesenchymal stem cells exerts antiapoptotic effects in adult rats after spinal cord injury. Stem Cells Int. 2015;2015:516215.","DOI":"10.1155\/2015\/516215"},{"key":"687_CR19","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/stem.2785","volume":"36","author":"ED Gomes","year":"2018","unstructured":"Gomes ED, Mendes SS, Assun\u00e7\u00e3o\u2010Silva RC, Teixeira FG, Pires AO, Anjo SI, et al. Co\u2010transplantation of adipose tissue\u2010derived stromal cells and olfactory ensheathing cells for spinal cord injury repair. Stem Cells. 2018;36:696\u2013708.","journal-title":"Stem Cells"},{"key":"687_CR20","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.4103\/1673-5374.280310","volume":"15","author":"R Reshamwala","year":"2020","unstructured":"Reshamwala R, Shah M, John JS, Ekberg J. The link between olfactory ensheathing cell survival and spinal cord injury repair: a commentary on common limitations of contemporary research. Neural Regen Res. 2020;15:1848\u20139.","journal-title":"Neural Regen Res"},{"key":"687_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.tins.2003.10.011","volume":"27","author":"SC Barnett","year":"2004","unstructured":"Barnett SC, Chang L. Olfactory ensheathing cells and CNS repair: going solo or in need of a friend? Trends Neurosci. 2004;27:54\u201360.","journal-title":"Trends Neurosci"},{"key":"687_CR22","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/BRS.0b013e31819403ce","volume":"34","author":"C Paul","year":"2009","unstructured":"Paul C, Samdani AF, Betz RR, Fischer I, Neuhuber B. Grafting of human bone marrow stromal cells into spinal cord injury: a comparison of delivery methods. Spine. 2009;34:328\u201334.","journal-title":"Spine."},{"key":"687_CR23","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1097\/01.brs.0000138273.02820.0a","volume":"29","author":"K Satake","year":"2004","unstructured":"Satake K, Lou J, Lenke LG. Migration of mesenchymal stem cells through cerebrospinal fluid into injured spinal cord tissue. Spine. 2004;29:1971\u20139.","journal-title":"Spine."},{"key":"687_CR24","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00586-014-3416-6","volume":"24","author":"L Li","year":"2015","unstructured":"Li L, Adnan H, Xu B, Wang J, Wang C, Li F, et al. Effects of transplantation of olfactory ensheathing cells in chronic spinal cord injury: a systematic review and meta-analysis. Eur Spine J. 2015;24:919\u201330.","journal-title":"Eur Spine J"},{"key":"687_CR25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.expneurol.2006.04.035","volume":"201","author":"MY Macias","year":"2006","unstructured":"Macias MY, Syring MB, Pizzi MA, Crowe MJ, Alexanian AR, Kurpad SN. Pain with no gain: allodynia following neural stem cell transplantation in spinal cord injury. Exp Neurol. 2006;201:335\u201348.","journal-title":"Exp Neurol"},{"key":"687_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/10790268.2006.11753874","volume":"29","author":"C Lima","year":"2006","unstructured":"Lima C, Pratas-Vital J, Escada P, Hasse-Ferreira A, Capucho C, Peduzzi JD. Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study. J Spinal Cord Med. 2006;29:191\u2013203.","journal-title":"J Spinal Cord Med"},{"key":"687_CR27","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/sj.sc.3102009","volume":"45","author":"M Tuszynski","year":"2007","unstructured":"Tuszynski M, Steeves J, Fawcett J, Lammertse D, Kalichman M, Rask C, et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion\/exclusion criteria and ethics. Spinal Cord. 2007;45:222\u201331.","journal-title":"Spinal Cord"},{"key":"687_CR28","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1093\/brain\/awh657","volume":"128","author":"F Feron","year":"2005","unstructured":"Feron F, Perry C, Cochrane J, Licina P, Nowitzke A, Urquhart S, et al. Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain. 2005;128:2951\u201360.","journal-title":"Brain."},{"key":"687_CR29","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/sj.sc.3102010","volume":"45","author":"D Lammertse","year":"2007","unstructured":"Lammertse D, Tuszynski M, Steeves J, Curt A, Fawcett J, Rask C, et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design. Spinal Cord. 2007;45:232\u201342.","journal-title":"Spinal Cord"},{"key":"687_CR30","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/sj.sc.3102007","volume":"45","author":"J Fawcett","year":"2007","unstructured":"Fawcett J, Curt A, Steeves J, Coleman W, Tuszynski M, Lammertse D, et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord. 2007;45:190\u2013205.","journal-title":"Spinal Cord"}],"container-title":["Spinal Cord"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41393-021-00687-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41393-021-00687-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41393-021-00687-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T19:07:12Z","timestamp":1641496032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41393-021-00687-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["687"],"URL":"https:\/\/doi.org\/10.1038\/s41393-021-00687-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-435425\/v1","asserted-by":"object"}]},"ISSN":["1362-4393","1476-5624"],"issn-type":[{"value":"1362-4393","type":"print"},{"value":"1476-5624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,9]]},"assertion":[{"value":"19 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was designed in accordance with the 1964 Declaration of Helsinki and was approved by the Ethics in Medical Research Committee of Tarbiat Modares University (IR.TMU.REC.1396.737). We certify that all applicable institutional and governmental regulations concerning the ethical use of human volunteers were followed during the course of this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}